Kung Winston
Related Filers (4)
- PMV Pharmaceuticals, Inc. (13)
- Janux Therapeutics, Inc. (3)
- Alliqua BioMedical, Inc. (1)
- ArriVent Biopharma, Inc. (1)
- Show More ...
Ownership (18)
3
Thursday, 1/25/2024
ArriVent Biopharma, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/16/2023
Janux Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/15/2023
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 1/30/2023
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/22/2022
Janux Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/22/2022
Janux Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 4/21/2022
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 2/28/2022
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/8/2022
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 8/20/2021
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/4/2021
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/8/2021
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/8/2021
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/7/2021
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/4/2021
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/31/2020
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 9/24/2020
PMV Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities
3
Monday, 2/29/2016
Alliqua BioMedical, Inc.: Initial statement of beneficial ownership of securities